Related Experiment Video
Updated: Aug 14, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Predictors of hypertension and changes of blood pressure in HIV-infected patients
Rodolphe Thiébaut1, Wafaa M El-Sadr, Nina Friis-Møller
1INSERM E0338 epsilont U593, ISPED, Université Victor Segalen Bordeaux 2, Bordeaux, France. rodolphe.thiebaut@isped.u-bordeaux2.fr
Insights
Hypertension risk in HIV patients increases with age, male sex, higher BMI, and baseline blood pressure. Antiretroviral drugs showed no adverse effect, with non-nucleoside reverse transcriptase inhibitors potentially lowering hypertension risk.
Area of Science:
- Cardiology
- Infectious Diseases
- Pharmacology
Background:
- Hypertension is a significant concern in individuals with HIV.
- Understanding predictors of blood pressure changes and hypertension development is crucial for managing cardiovascular risk in this population.
Purpose of the Study:
- To identify predictors of changes in systolic blood pressure (SBP) and diastolic blood pressure (DBP) during follow-up.
- To assess predictors of hypertension development in HIV-infected individuals.
Main Methods:
- Longitudinal analysis of blood pressure (BP) changes using mixed-effects models in 17,170 HIV-1-infected patients from the D:A:D study.
- Cox models were used to assess predictors of hypertension development in 8,984 patients with normal baseline BP.
Main Results:
- Older age, male sex, higher body mass index (BMI), and use of BP-lowering drugs were associated with increased SBP and DBP.
- Hypertension developed in 1186 patients (incidence 72.1 per 1000 person-years), with predictors including male sex, higher BMI, older age, higher baseline BP, high total cholesterol, and clinical lipodystrophy.
- No association was found between exposure to nucleoside reverse transcriptase inhibitors or protease inhibitors and hypertension risk. Exposure to non-nucleoside reverse transcriptase inhibitors (NNRTIs) was associated with a lower risk of hypertension.
Conclusions:
- Established hypertension risk factors are associated with increased blood pressure in HIV-infected individuals.
- No independent detrimental effect of antiretroviral drug classes on BP was observed.
- Non-nucleoside reverse transcriptase inhibitors (NNRTIs) showed a potential protective association against hypertension development.
Objective:
We assessed predictors of changes in systolic (SBP) and diastolic (DBP) blood pressure during follow-up and of the development of hypertension in HIV-infected individuals.
Methods:
International cohort collaborative study (D:A:D) of established prospective cohorts of HIV-1-infected patients. Longitudinal analysis of changes in blood pressure (BP) was performed using mixed effects models in 17170 patients. Predictors of development of hypertension during follow-up (systolic BP > or =140 and/or diastolic BP > or =90 mmHg or initiation of antihypertensive treatment) were assessed using Cox models in 8 984 patients with a normal BP level at baseline.
Results:
73548 BP measurements with a median of 4 per patient (interquartile range [IQR]: 2-6) were recorded over a median follow-up of 2.3 years (IQR: 1.5-2.6). Risk factors significantly associated with a development of higher systolic BP and diastolic BP (differences > or =5 mmHg and P-values <0.001) during follow-up were: older age, male sex, higher body mass index (BMI) and use of BP-lowering drugs. In patients with normal BP at baseline, 1186 developed hypertension for an incidence of 72.1 per 1000 person-years (95% confidence interval: 68.2-76.0). Factors associated with development of hypertension were: male sex, higher BMI, older age, higher BP at baseline, high total cholesterol and clinical lipodystrophy. Cumulative duration of exposure to nucleoside reverse transcriptase inhibitors (P=0.75), protease inhibitors (P=0.92) as well as type of antiretroviral treatment at baseline (P=0.18) were not associated with a higher risk of hypertension. Cumulative duration of exposure to non-nucleoside reverse transcriptase inhibitors (NNRTIs) was significantly associated with lower risk of hypertension (hazard ratio=0.78 and 0.67 for those treated < or =10 months and >10 months compared with no exposure; P=0.005).
Conclusions:
Increased blood pressure in HIV-infected individuals is associated with established risk factors for hypertension. There was no evidence for an independent deleterious effect of any class of antiretroviral drugs on BP, although the use of NNRTIs was associated with a lower risk of development of hypertension.
Related Concept Videos
Factors affecting Blood pressure
Physiological Factors:
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...
Errors occurring during blood pressure monitoring
Several factors...
Hypertension V: Nursing Management